Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Serina Therapeutics (SER)
NYSE MKT:SER
RESEARCH TOOLSreports
Serina Therapeutics (SER) Financial Statements
180 Followers
Serina Therapeutics Financial Overview
| Dec 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 56.00K | $ 9.00K | $ 10.00K | $ 8.00K | $ 9.00K |
| Gross Profit | $ 55.00K | $ 4.00K | $ 9.00K | $ 7.00K | $ 4.00K |
| EBIT | $ -3.47M | $ -1.89M | $ 2.14M | $ -1.78M | $ -1.51M |
| EBITDA | $ -3.32M | $ -936.00K | $ 3.23M | $ -834.00K | $ -1.48M |
| Net Income Common Stockholders | $ -3.46M | $ -2.67M | $ -2.23M | $ -2.70M | $ -2.44M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 345.00K | $ 261.00K | $ 280.00K | $ 645.00K | $ 466.00K |
| Total Assets | $ 11.96M | $ 12.28M | $ 12.53M | $ 3.24M | $ 2.01M |
| Total Debt | $ 4.37M | $ 33.01M | $ 30.05M | $ 18.12M | $ 15.65M |
| Net Debt | $ 4.02M | $ 32.75M | $ 29.77M | $ 17.48M | $ 15.18M |
| Total Liabilities | $ 6.61M | $ 34.34M | $ 32.54M | $ 20.56M | $ 17.16M |
| Stockholders Equity | $ 5.47M | $ -22.18M | $ -19.89M | $ -17.21M | $ -15.10M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -2.05M | $ -2.02M | $ -1.86M | $ -1.32M | $ -1.24M |
| Operating Cash Flow | $ -2.05M | $ -2.02M | $ -1.86M | $ -1.32M | $ -1.24M |
| Investing Cash Flow | - | - | $ -10.00M | - | $ 0.00 |
| Financing Cash Flow | $ 2.00M | $ 2.00M | $ 11.50M | $ 1.50M | $ 1.00M |
Serina Therapeutics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.